SCHEMBL341854

SCHEMBL341854

CB1OC(C)(C)C(C)(C(C)C)O1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.33
LAP3 P28838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19146397 0.80 ANPEP (0.31) ANPEPLAP3
SCHEMBL7886858 0.74 ANPEP (0.39) ANPEPLAP3
SCHEMBL14399 0.73 ANPEP (0.38) ANPEPLAP3
SCHEMBL24246044 0.69 ANPEP (0.30) ANPEPLAP3
SCHEMBL20625972 0.67
SCHEMBL21887131 0.67
SCHEMBL1262419 0.64
SCHEMBL21581099 0.62 ANPEP (0.38) ANPEPLAP3
SCHEMBL12719694 0.61
SCHEMBL24502686 0.61 LPL (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134809-B1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE INCLUDING ELECTRON TRANSPORTING UNIT AND HOLE TRANSPORTING UNIT, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL IND INC (KR) 2020-09-02 EP disclosed
US-9595677-B2 Material for organic photoelectric device, and organic photoelectric device including the same CHEIL INDUSTRIES, INC. (KR) 2017-03-14 US disclosed
EP-2376594-B1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL IND INC (KR) 2016-07-06 EP disclosed
US-9199966-B2 Compound for an organic photoelectric device, organic photoelectric device, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2015-12-01 US disclosed
US-20130099214-A1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2013-04-25 US disclosed
US-8399108-B2 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same CHEIL INDUSTRIES, INC. (KR) 2013-03-19 US disclosed
US-8343640-B2 Material for organic photoelectric device, and organic photoelectric device including the same CHEIL INDUSTRIES, INC. (KR) 2013-01-01 US disclosed
US-20120280221-A1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE INCLUDING ELECTRON TRANSPORTING UNIT AND HOLE TRANSPORTING UNIT, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
US-8247805-B2 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same CHEIL INDUSTRIES, INC. (KR) 2012-08-21 US disclosed
US-8120243-B2 Material for organic photoelectric device, and organic photoelectric device thereby CHEIL INDUSTRIES, INC. (KR) 2012-02-21 US disclosed
US-20090099177-A1 PYRIDYL COMPOUNDS GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
WO-2009031855-A1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES INC. (KR) 2009-03-12 WO disclosed
EP-1833795-B1 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LTD (GB) 2009-03-04 EP disclosed
EP-2013181-A1 PYRIDYL COMPOUNDS Glaxo Group Limited (GB) 2009-01-14 EP disclosed
WO-2008147110-A2 MATERIAL FOR ORGANIC ELECTRO-OPTICAL DEVICE HAVING FLUORENE DERIVATIVE COMPOUND AND ORGANIC ELECTRO-OPTICAL DEVICE INCLUDING THE SAME CHEIL INDUSTRIES INC. (KR) 2008-12-04 WO disclosed
WO-2008127057-A1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE INCLUDING ELECTRON TRANSPORTING UNIT AND HOLE TRANSPORTING UNIT, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES INC. (KR) 2008-10-23 WO disclosed
US-20080249138-A1 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases MARTIN PAUL GIBLIN GERARD 2008-10-09 US disclosed
WO-2007128752-A1 PYRIDYL COMPOUNDS GLAXO GROUP LIMITED (GB) 2007-11-15 WO disclosed
EP-1833795-A1 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2007-09-19 EP disclosed
WO-2006066968-A1 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280221-A1 MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE INCLUDING ELECTRON TRANSPORTING UNIT AND HOLE TRANSPORTING UNIT, AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME SLC25A21, MCU, SLC25A11 ANPEP 4069/4885LAP3 3876/4885
US-20080249138-A1 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases PTGER1, PTGDR, PTGER4 ANPEP 4467/4885LAP3 4173/4885
US-20090099177-A1 PYRIDYL COMPOUNDS CYP2C19, CYP4F3, C5 ANPEP 3396/4885LAP3 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.